U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pinealoma (trilateral retinoblastoma)

MedGen UID:
401200
•Concept ID:
C1867294
•
Neoplastic Process

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPinealoma (trilateral retinoblastoma)

Professional guidelines

PubMed

Trilateral retinoblastoma: insights into histogenesis and management.
Marcus DM, Brooks SE, Leff G, McCormick R, Thompson T, Anfinson S, Lasudry J, Albert DM
Surv Ophthalmol 1998 Jul-Aug;43(1):59-70. doi: 10.1016/s0039-6257(98)00019-8. PMID: 9716194

Recent clinical studies

Etiology

Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst 2023 Sep;39(9):2273-2284. Epub 2022 Aug 16 doi: 10.1007/s00381-022-05637-x. PMID: 35972537
Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis.
de Jong MC, Shaikh F, Gallie B, Kors WA, Jansen RW, Dommering C, de Graaf P, Moll AC, Dimaras H, Shroff M, Kivelä TT, Soliman SE
Acta Ophthalmol 2022 Feb;100(1):e47-e52. Epub 2021 May 3 doi: 10.1111/aos.14855. PMID: 33939299Free PMC Article
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL
Br J Ophthalmol 2018 Nov;102(11):1597-1601. Epub 2018 Aug 27 doi: 10.1136/bjophthalmol-2018-312263. PMID: 30150278
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission.
Rodjan F, de Graaf P, Brisse HJ, Göricke S, Maeder P, Galluzzi P, Aerts I, Alapetite C, Desjardins L, Wieland R, Popovic MB, Diezi M, Munier FL, Hadjistilianou T, Knol DL, Moll AC, Castelijns JA
J Neurooncol 2012 Sep;109(3):535-44. Epub 2012 Jul 18 doi: 10.1007/s11060-012-0922-4. PMID: 22802019Free PMC Article
Second primary tumors in patients with retinoblastoma. A review of the literature.
Moll AC, Imhof SM, Bouter LM, Tan KE
Ophthalmic Genet 1997 Mar;18(1):27-34. doi: 10.3109/13816819709057880. PMID: 9134547

Diagnosis

Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta-analysis.
de Jong MC, Shaikh F, Gallie B, Kors WA, Jansen RW, Dommering C, de Graaf P, Moll AC, Dimaras H, Shroff M, Kivelä TT, Soliman SE
Acta Ophthalmol 2022 Feb;100(1):e47-e52. Epub 2021 May 3 doi: 10.1111/aos.14855. PMID: 33939299Free PMC Article
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL
Br J Ophthalmol 2018 Nov;102(11):1597-1601. Epub 2018 Aug 27 doi: 10.1136/bjophthalmol-2018-312263. PMID: 30150278
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission.
Rodjan F, de Graaf P, Brisse HJ, Göricke S, Maeder P, Galluzzi P, Aerts I, Alapetite C, Desjardins L, Wieland R, Popovic MB, Diezi M, Munier FL, Hadjistilianou T, Knol DL, Moll AC, Castelijns JA
J Neurooncol 2012 Sep;109(3):535-44. Epub 2012 Jul 18 doi: 10.1007/s11060-012-0922-4. PMID: 22802019Free PMC Article
Trilateral retinoblastoma.
Antoneli CB, Ribeiro Kde C, Sakamoto LH, Chojniak MM, Novaes PE, Arias VE
Pediatr Blood Cancer 2007 Mar;48(3):306-10. doi: 10.1002/pbc.20793. PMID: 16572402
Trilateral retinoblastoma: insights into histogenesis and management.
Marcus DM, Brooks SE, Leff G, McCormick R, Thompson T, Anfinson S, Lasudry J, Albert DM
Surv Ophthalmol 1998 Jul-Aug;43(1):59-70. doi: 10.1016/s0039-6257(98)00019-8. PMID: 9716194

Therapy

Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL
Br J Ophthalmol 2018 Nov;102(11):1597-1601. Epub 2018 Aug 27 doi: 10.1136/bjophthalmol-2018-312263. PMID: 30150278
Trilateral retinoblastoma: potentially curable with intensive chemotherapy.
Dunkel IJ, Jubran RF, Gururangan S, Chantada GL, Finlay JL, Goldman S, Khakoo Y, O'Brien JM, Orjuela M, Rodriguez-Galindo C, Souweidane MM, Abramson DH
Pediatr Blood Cancer 2010 Mar;54(3):384-7. doi: 10.1002/pbc.22336. PMID: 19908299
Trilateral retinoblastoma.
Antoneli CB, Ribeiro Kde C, Sakamoto LH, Chojniak MM, Novaes PE, Arias VE
Pediatr Blood Cancer 2007 Mar;48(3):306-10. doi: 10.1002/pbc.20793. PMID: 16572402
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF
Arch Ophthalmol 2001 Sep;119(9):1269-72. doi: 10.1001/archopht.119.9.1269. PMID: 11545631
Trilateral retinoblastoma.
Meadows A
Med Pediatr Oncol 1986;14(6):323-6. doi: 10.1002/mpo.2950140609. PMID: 3784984

Prognosis

Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst 2023 Sep;39(9):2273-2284. Epub 2022 Aug 16 doi: 10.1007/s00381-022-05637-x. PMID: 35972537
Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL
Br J Ophthalmol 2018 Nov;102(11):1597-1601. Epub 2018 Aug 27 doi: 10.1136/bjophthalmol-2018-312263. PMID: 30150278
Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission.
Rodjan F, de Graaf P, Brisse HJ, Göricke S, Maeder P, Galluzzi P, Aerts I, Alapetite C, Desjardins L, Wieland R, Popovic MB, Diezi M, Munier FL, Hadjistilianou T, Knol DL, Moll AC, Castelijns JA
J Neurooncol 2012 Sep;109(3):535-44. Epub 2012 Jul 18 doi: 10.1007/s11060-012-0922-4. PMID: 22802019Free PMC Article
Trilateral retinoblastoma.
Antoneli CB, Ribeiro Kde C, Sakamoto LH, Chojniak MM, Novaes PE, Arias VE
Pediatr Blood Cancer 2007 Mar;48(3):306-10. doi: 10.1002/pbc.20793. PMID: 16572402
Second primary tumors in patients with retinoblastoma. A review of the literature.
Moll AC, Imhof SM, Bouter LM, Tan KE
Ophthalmic Genet 1997 Mar;18(1):27-34. doi: 10.3109/13816819709057880. PMID: 9134547

Clinical prediction guides

Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV, Sampor C, Laurent VE, Aschero R, Iyer S, Rossi J, Alderete D, Alonso DF, Szijan I, Chantada GL
Br J Ophthalmol 2018 Nov;102(11):1597-1601. Epub 2018 Aug 27 doi: 10.1136/bjophthalmol-2018-312263. PMID: 30150278
Pathology of pineal parenchymal tumors.
Sato K, Kubota T
Prog Neurol Surg 2009;23:12-25. Epub 2009 Mar 23 doi: 10.1159/000210050. PMID: 19329858
Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF
Arch Ophthalmol 2001 Sep;119(9):1269-72. doi: 10.1001/archopht.119.9.1269. PMID: 11545631
S-antigen immunoreactivity in trilateral retinoblastoma.
Donoso LA, Rorke LB, Shields JA, Augsburger JJ, Brownstein S, Lahoud S
Am J Ophthalmol 1987 Jan 15;103(1):57-62. doi: 10.1016/s0002-9394(14)74170-4. PMID: 3541632
Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma.
Bader JL, Meadows AT, Zimmerman LE, Rorke LB, Voute PA, Champion LA, Miller RW
Cancer Genet Cytogenet 1982 Mar;5(3):203-13. doi: 10.1016/0165-4608(82)90026-7. PMID: 7066879

Recent systematic reviews

Retinoblastoma associated with chromosomal 13q14 deletion mosaicism.
Kivelä T, Tuppurainen K, Riikonen P, Vapalahti M
Ophthalmology 2003 Oct;110(10):1983-8. doi: 10.1016/S0161-6420(03)00484-6. PMID: 14522775

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...